FGFR3 GENE ALTERATION

Clinical trials for FGFR3 GENE ALTERATION explained in plain language.

Never miss a new study

Get alerted when new FGFR3 GENE ALTERATION trials appear

Sign up with your email to follow new studies for FGFR3 GENE ALTERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New targeted drug trial aims to control advanced cancers with specific gene fault

Disease control Ongoing

This study is testing an investigational drug called TYRA300 for people with advanced bladder cancer and other solid tumors that have specific changes in a gene called FGFR3. The main goals are to find a safe and effective dose and to see if the drug can shrink or control the tum…

Matched conditions: FGFR3 GENE ALTERATION

Phase: PHASE1, PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

FGFR3 GENE ALTERATION

Get alerted when new FGFR3 GENE ALTERATION trials appear

New targeted drug trial aims to control advanced cancers with specific gene fault